PA
OCDX

Parallel Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Parallel Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-31
Closed -$1K – 3509
2022
Q1 		$1K Buy
31
+12
+63% +$216 ﹤0.01% 2913
2021
Q4 		$0 Buy
+19
New +$374 ﹤0.01% 3414

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Parallel Advisors's OCDX Position: Q2 2022 in Review

Parallel Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 31 shares — an estimated $1K sold.

Parallel Advisors first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Parallel Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Parallel Advisors sold 31 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1K.
  • Parallel Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
  • Parallel Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Parallel Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.